Chris Lewis

Stock Analyst at Roth Capital

(2.90)
# 1,326
Out of 5,182 analysts
10
Total ratings
71.43%
Success rate
63.98%
Average return

Stocks Rated by Chris Lewis

Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $9.57
Upside: -58.20%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $93.56
Upside: -82.90%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $34.46
Upside: -57.92%
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.03
Upside: +1,841.75%